Diana Bello
ScholarGPS® ID: 17056008884683
Affiliation History
Field
Life Sciences
Discipline
Genetics
Metrics Summary
Publication Count
2
Predicted Citations
27
Predicted h-index
1
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Prediction of pCR with pretreatment MRI radiomics in triple negative breast cancer treated with neoadjuvant chemo-immunotherapy. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 589-589 (2024). |
TOPOLOGY: A phase II study to evaluate the efficacy and toxicities of PLX038, in patients with locally advanced or metastatic triple-negative breast cancer. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS1142-TPS1142 (2024). |
Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT) (journal article) JCO Precision Oncology (2021). |
Alpelisib and fulvestrant efficacy in HR-positive HER2-negative -mutant advanced breast cancer: Data from the French early access program. (journal article) Journal of Clinical Oncology, volume 39, issue 15_suppl, pages 1064-1064 (2021). |